Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | PHVS | RAPP | ||
| Company | Provention Bio Inc | Pharvaris N.V. | Rapport Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 36.13 | 48.58 | ||
| High | 25.00 | 36.82 | 48.78 | ||
| Low | 24.98 | 35.45 | 47.00 | ||
| Last | 24.98 | 36.39 | 47.85 | ||
| Change | +0.75 | +0.12 | -1.22 | ||
| Percent Change | +3.10% | +0.33% | -2.49% | ||
| Volume | 9,124,100 | 627,700 | 323,700 | ||
| 20-Day Average Volume | 2,505,925 | 569,815 | 283,975 | ||
| Previous | 24.23 | 36.27 | 49.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 34.44 | 44.97 | ||
| 20-Day Raw Stochastic | 98.15% | 90.04% | 79.80% | ||
| 20-Day Relative Strength | 79.66 | 57.68 | 60.87 | ||
| Weighted Alpha | +19.60 | +64.49 | +137.03 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | +6.90% since 08/13/26 | +1.03% since 08/13/26 | ||
| Low | 24.20 on 04/25/23 | 33.54 on 08/14/26 | 46.37 on 08/14/26 | ||
| High | 25.00 on 04/26/23 | 36.88 on 08/19/26 | 49.90 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +8.46% since 07/20/26 | +19.00% since 07/20/26 | ||
| Low | 23.82 on 03/27/23 | 31.51 on 08/03/26 | 39.75 on 08/03/26 | ||
| High | 25.00 on 04/26/23 | 36.93 on 08/13/26 | 49.90 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | +23.57% since 05/20/26 | +33.96% since 05/20/26 | ||
| Low | 6.59 on 03/10/23 | 28.46 on 06/02/26 | 33.51 on 06/11/26 | ||
| High | 25.00 on 04/26/23 | 36.93 on 08/13/26 | 49.90 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | +29.50% since 02/20/26 | +60.79% since 02/20/26 | ||
| Low | 6.38 on 10/28/22 | 24.95 on 03/24/26 | 26.01 on 03/19/26 | ||
| High | 25.00 on 04/26/23 | 36.93 on 08/13/26 | 49.90 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,372,348 | 2,354,281 | ||
| Shares Outstanding, K | 94,781 | 65,408 | 47,978 | ||
| Annual Sales, $M | 12,900,000 | 0 | 0 | ||
| Annual Net Income, $M | -113,570,000 | -198,790,000 | -111,480,000 | ||
| Last Qtr Sales, $M | 10,810,000 | 0 | 20,000,000 | ||
| Last Qtr Income, $M | -33,280,000 | -55,630,000 | -19,860,000 | ||
| 60-Month Beta | 2.47 | -2.31 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -0.81 on 08/12/26 | -1.19 on 08/05/26 | ||
| Latest Earnings Date | 05/04/23 | 11/11/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||